The limited numbers of in-vitro studies on various glioma cell lines revealed a considerable degree of variability of LRP-1 mRNA expression with significantly higher levels in SF-539, U-87 MG, and U-343 MG cells lines (16, 17). This evidence concerns the gene LRP1 and central nervous system cancer.